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Abstract Mechanosensation and mechanotransduction are
fundamental aspects of biology, but the link between physical
stimuli and biological responses remains not well understood.
The perception of mechanical stimuli, their conversion into
biochemical signals, and the transmission of these signals are
particularly important for dynamic organs such as the heart.
Various concepts have been introduced to explain
mechanosensation at the molecular level, including effects
on signalosomes, tensegrity, or direct activation (or inactiva-
tion) of enzymes. Striated muscles, including cardiac
myocytes, differ from other cells in that they contain sarco-
meres which are essential for the generation of forces and
which play additional roles in mechanosensation. The major-
ity of cardiomyopathy causing candidate genes encode struc-
tural proteins among which titin probably is the most impor-
tant one. Due to its elastic elements, titin is a length sensor and
also plays a role as a tension sensor (i.e., stress sensation). The
recent discovery of titin mutations being a major cause of
dilated cardiomyopathy (DCM) also underpins the importance
of mechanosensation and mechanotransduction in the patho-
genesis of heart failure. Here, we focus on sarcomere-related
mechanisms, discuss recent findings, and provide a link to
cardiomyopathy and associated heart failure.
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Introduction
Mechanosensation is a fundamental process in biology [23]
and particularly important for the heart [17]. However,
mechanosensation is a broadly applied term with no clear
definition in the biological sciences. There are different types
of mechanical stimuli and it is important to differentiate be-
tween them. Stress (σ) (dimension: newton per square meter)
is physically defined by:
σ ¼ F
A
where F is the applied force per unit area (A). Also, “shear
stress” (τ) (dimension: newton per square meter), where the




Other types of physical stresses such as compression and
torsion may also occur and are equally important. Distinct




where L0 is the initial length and ΔL is the change in length.
Another important parameter is Young’s modulus (dimension:
newton per square meter), which is a measure of the stiffness:
E ¼ σ
ε
Cells are able to detect stress and strain via changes in
conformation of proteins or macromolecular protein com-
plexes, but the precise molecular mechanisms remain un-
clear. In this regard, two different models have been devel-
oped to explain mechanosensory behavior (Table 1): (1)
the localized and (2) the decentralized model. The local-
ized model proposes that changes at the cell membrane are
sensed immediately and are transmitted from there to other
parts of the cell. In contrast, the decentralized model pro-
poses that any force applied at the cell surface will cause
deformations of elastic cytoskeletal components and, as
such, can be sensed far away from the area of impact. The
latter model is also called the “tensegrity” model (derived
from tensional integrity) based on Buckminster Fuller’s
geodesic dome.
The concept of tensegrity has profound consequences for
cell biology as it implies that nearly every protein is involved
in mechanosensation and mechanotransduction. Therefore,
naturally occurring mutations in these components or com-
plete loss of these components such as those observed in
mouse knockout studies are all expected to affect
mechanosensory functions.
Different mechanosensory protein complexes can be found
in cardiac myocytes: (1) cell membrane associated, (2) intra-
cellular embedded, and (3) sarcomere related (Table 1). All
these various signalosomes are sensitive to different types of
mechanical stimuli. For example, a deformation of the cell
membrane may be detected by cell membrane-associated
signalosomes, such as stretch-activated channels, angiotensin
receptors, the caveolae, and integrin-mediated signaling. De-
pending on severity and duration, these events may also be
sensed by intermediate filaments and/or by sarcomere-
associated signalosomes. Here, we focus on mechanical stim-
uli and try to put them into a physiological perspective (please
see [29] for a recent review on hormonal stimulators of
hypertrophy).
Heart failure, hypertrophy, and mechanical forces
Heart failure is the leading cause of death worldwide [26].
While we continue to unravel the genetic basis of heart failure
and while the equilibrium between cardiomyocyte loss and
regeneration is severely damaged in heart failure, the func-
tional link between both and how mechanical forces influence
these events remain not well understood [33]. This fact is
underscored by the recent discovery that the frequency of
potential heart failure causing mutations is much higher than
the prevalence of heart failure itself [14]. It might well be that
the magnitude of mechanical forces combined with genetic
defects in mechanosensation or mechanotransduction triggers
pathological effects and disease. Cardiac hypertrophy (or re-
modeling [19]) and its reverse, cardiac atrophy, are triggered,
among others, by an increase or decrease in physical stress,
respectively. At the organ level, these changes lead to signif-
icant remodeling processes, including changes in angiogene-
sis and the composition of the extracellular matrix [19].
At the cellular level, cardiac hypertrophy and atrophy are
associated with an increase or decrease in cell size, respec-
tively, which alone poses a tremendous challenge for every
cell. These changes are particularly important for cardiac
myocytes not only because new sarcomeres have to be added
in parallel (during pressure overload) or in series (during
volume overload) or they have to be removed in atrophy
which can be described as remodeling in three dimensions.
However, membrane constituents have to increase or decrease
proportionately which can be described as remodeling in two
dimensions. Due to transcription factors being unable to sep-
arately regulate single genes (i.e., there are no specific sets of
transcription factors available to separately regulate the tran-
scription of membrane or cellular components), membrane
and cellular components have to change proportionately and
a new equilibrium has to be found, which is only possible
within certain limits. Therefore, it is no surprise that lethality
after myocardial infarction is highest immediately in the days
after the incident where remodeling occurs [44]. Interestingly,
these arrhythmias can be efficiently terminated by overexpres-
sion of a dominant negative mechanosensitive KCNH2 chan-
nel (KCNH2-G628S) or by application of the KCNH2 chan-
nel blocker dofetilide [1]. This result is interesting because
ischemia/reperfusion is associated with changes in the expres-
sion of a multitude of mechanosensitive channels such as
TRPC6 [24] (please see for a brief review: [47]). Moreover,
stretch is known to have a preconditioning effect on ischemia/
reperfusion [39] which is sensitive to the inhibition of KATP
channels [36]; therefore, interferencewithKCNH2 could have
a negative impact on cell survival. TRPC6 is regulated by the
calcineurin/nuclear factor of activated Tcells (NFAT) pathway
[24] and negatively regulates endothelin which leads to
antifibrotic effects—a hallmark of physiological hypertrophy
[29]. Also, overexpression of calcineurin has protective
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effects in a murine model of dilated cardiomyopathy (DCM)
[13]. While calcineurin/NFAT signaling is largely seen as an
inductor of pathological hypertrophy, this pathway can also
play a role in physiological hypertrophy.
Therefore, we argue that no signal transduction pathway is
adaptive or maladaptive, rather the strength of the stimulus, its
nature (i.e., persistent such as in aortic constriction or intermit-
tent such as during exercise), and the genetic composition of
the organism will decide if the stimulus results in heart failure.
Although models have been reported whereby hypertrophy
was not necessary to sustain elevated biomechanical stress
[7], hypertrophy, within limits and if reversible, is initially
beneficial. From a signaling point of view, hypertrophy is
expected to prolong, while atrophy is expected to shorten
signal transduction from the cell membrane to the nucleus.
Sarcomere-related mechanisms of mechanosensation
In contrast to other cell types, striated muscle cells are unique
in that their primary function is to generate forces which
enable the circulation of blood or movement of the body.
These forces need to be “fine-tuned” and carefully controlled
which may be defined as “sensing of the magnitude and
dynamics of contractility,” as opposed to the well-known
concepts of the “perception of extracellular mechanical stim-
uli”—a general description of mechanosensation which can
be found in every living cell [22]. From this point of view, it is
therefore not surprising that several mechanosensitive
signalosomes are present in sarcomeres (Fig. 1).
During the course of the last decade, much attention has
been focused on the passive elastic components of the sarco-
mere as mechanosensors, particularly the giant proteins titin,
nebulin (nebulette in the heart), and obscurin [29]. However,
Z-disc-related mechanosensation remains not well under-
stood. The Z-disc is made up of a lattice of α-actinin mole-
cules, which anchor the ends of actin filaments, and thus
transmits force from the molecular motor to adjacent sarco-
meres and ultimately to the ends of the contractile cell. Apart
from transmitting forces to the ends of the cell, each Z-disc is
also connected to the extracellular matrix (ECM). Hence,
force transmission to the cavity of the heart also, and maybe
predominantly, occurs via the Z-disc-integrin-ECM mechani-
cal pathway. The Z-disc is flexible and muscle shortening,
which causes high systolic wall stress, changes the conforma-
consisting of muscle LIM protein (MLP, CSRP3), telethonin
(TCAP), and the amino-terminal titin [18]. Loss of MLP in
genetically altered animals or MLP mutations in humans are
associated with various types of cardiomyopathy and associ-
ated heart failure. For example, the 10 T→C (Trp4Arg)
MLP missense mutation has been identified in several
cardiomyopathy patients and is present at high frequencies
(up to 1 %) in some European populations [20], and the
corresponding knock-in animals develop an age and gene
dosage-dependent hypertrophic cardiomyopathy and heart
failure phenotype. At the molecular level, this mutation is
associated with significantly decreased MLP mRNA and pro-
tein levels. Loss ofMLP has also been reported in heart failure
[50], and loss of MLP-mediated signaling may contribute to
the development of this condition. Furthermore,W4R-MLP is
associated with loss of affinity to its binding partner telethonin
and translocates from the sarcomeric Z-disc to the nucleus (for
more detailed reviews on MLP, please see: [6, 10]).
Telethonin (also known as titin-cap or t-cap) is a 19-kDa Z-
disc protein with a unique β-sheet structure which assembles
in a palindromic way with the N-terminal portion of titin [51]
and thereby may constitute a signalosome participating in the
process of cardio-mechanosensing. A variety of telethonin
mutations are associated with the development of congenital
diseases, including limb girdle muscular dystrophy 2G [8, 35,
38], hypertrophic cardiomyopathy (HCM), DCM [4, 12, 18],
and intestinal pseudo-obstruction [32].
Telethonin-deficient and transgenic animals were generat-
ed, and it was shown that this protein is not an indispensable
component of the titin-anchoring system, nor is deletion of the
gene or cardiac-specific overexpression associated with a
spontaneous cardiac phenotype, at least in mouse. It was
found that a main novel function of telethonin is to modulate
the turnover of the proapoptotic tumor suppressor p53 after
biomechanical stress in the nuclear compartment, thus linking
telethonin directly to apoptosis—a process which may be
called mechanoptosis (i.e., apoptosis after biomechanical
stress or a mechanosensitive type of cell death). In addition,
loss of telethonin mRNA and nuclear accumulation of this
protein is associated with human heart failure, an effect which
may contribute to enhanced rates of apoptosis found in these
hearts [21]. Mechanoptosis may be defined as a new type of
apoptosis found only in striated muscle which is (1) induced
via increased mechanical stress and (2) modified by muscle-
specific proteins such as telethonin. However, it remains to be
analyzed whether telethonin also affects other types of cell
death such as necroptosis or processes such as autophagy.
These data support the concept of using antiapoptotic strat-
egies to avoid the loss of cardiac myocytes [11]; however,
using growth factor treatment as an antiapoptotic strategy in
heart failure patients was not successful which possibly high-
lights our lack of knowledge of the underlying molecular
mechanisms and hence our inability to interfere [15].
In addition to the chronic adaptive mechanisms described
above, which are linked to gene expression, stretch also causes
a more immediate change in actomyosin cross-bridge kinetics.
It was recently shown that stretch applied to activated cardiac
trabeculae is related on a millisecond timescale to a rise in
force and to a decrease in Pi production and, therefore,
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tion of the α-actinin lattice. This may enable sensation of
tension (σ=F/A), which may involve a signalosome
decreased ATP hydrolysis, the latter lasting for the whole
duration of stretch [2, 30]. This property seems to be intrinsic
to the cardiac contractile apparatus and indicates an increase in
the force economy of the cross-bridges after stretch. The
change in the rate of Pi release may also affect homeostasis
of cellular energy metabolism through Pi feedback pathways
[45], which may be sensed by the adenosine monophosphate
kinase (AMPK), an enzyme already implicated in
mechanosensation—at least in epithelial cells [48]. In fact,
AMPK is localized to the nucleus and cytoplasm [43] and,
therefore, may well be able to sense changes in sarcomeric
AMP/ATP ratios. Moreover, mutations in this gene are a well-
known cause of HCM [3], and AMPK activity is necessary for
stress-related survival of many cell types, including tumor
cells [16]. Cardiomyopathies such as HCM are often associ-
ated with increased force production, but decreased efficiency.
AMPK may well be able to sense these changes and translate
them into long-term effects such as hypertrophy and/or cell
survival-related pathways. It would be interesting to analyze
these effects in heart failure, where βMHC is upregulated and
which is known to have slower ATPase activity.
N2A and N2B—titin mechanosensor complexes
With a molecular mass of up to 4.2 MDa, titin is the largest
molecule in biology and well known for its multiple functions
such as serving as a molecular ruler, its importance during
embryonic development, and for its role in providing mechan-
ical stability. Two isoforms of titin are found in the adult heart:
the N2B and N2BA isoforms. Both isoforms contain N2B,
PEVK, and multiple immunoglobulin (Ig) domains, with the
N2BA isoform also containing an additional N2A domain. All
of these domains unfold upon stretch and/or store energy
during every cycle of contraction and relaxation via entropic
springs [28].
Smaller mammals such as the rat and mouse express main-
ly the shorter and stiffer N2B isoform with larger mammals
expressing both the N2B and the longer and more compliant
N2BA isoform. During postnatal development, stiffness in-
creases due to switching of fetal cardiac titin (a more compli-
ant isoform) to adult N2B and N2BA isoforms. Diseases such
as DCM have also been shown to affect the N2BA/N2B ratio
to varying extents. An increase in titin-mediated stiffness has
been observed in a tachycardia-induced DCM canine model
[49], while a decrease in titin stiffness has been seen in
patients with end-stage DCM, whereas an increase has been
seen in patients with earlier stage disease [27]. It remains to be
elucidated whether different types of pathological stimuli,
species differences, early versus late effects of disease, or
different diseases per se specifically modify titin-mediated
stiffness.
The N2B domain binds specifically to four and a half LIM
protein 1 (FHL1), which in turn is the core of a signalosome
Fig. 1 Schematic representation of sarcomere-associated mechanosensory processes
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consisting of RAF, MEK1/2, and ERK2, thus connecting
growth factor-mediated Gq signaling and extracellular signals
to titin extensibility and finally to changes in gene expression.
Interestingly, loss of FHL1 blunts pathologic hypertrophy, and
as such, inhibition of this pathway might be beneficial [46].
Another important pathway is linked to the N2A elastic
titin domain, where the muscle ankyrin repeat proteins
(MARP) including cardiac ankyrin repeat protein (CARP),
ankrd2/Arpp, and DARP interact to constitute a signalosome
which responds to passive stretch in vitro [34].
Titin kinase mechanosensor complex
While titin’s elastic I-band domains may be able to primarily
sense strain and titin’s Z-disc anchored amino-terminus is
involved in the sensation of stress, titin also contains a kinase
domain which is involved in mechanosensation. Interestingly,
titin’s M-line domain contains a mechanically modulated ki-
nase able to bind and phosphorylate nbr1 and p62 in vitro.
MURF1 and 2 (and probably MURF3 which has not been
analyzed yet) also bind to this complex and will translocate
into the nucleus uponmechanical inactivity, where they down-
regulate and/or induce the nuclear export of serum response
factor (SRF) and, as such, aggravate the transcriptional atro-
phy program [5]. This is supported by the R279W-titin kinase
mutation which is associated with hereditary myopathy with
early respiratory failure (HMERF) and which leads to a dra-
matic loss of affinity to nbr1 [25]. Additional evidence for this
model is supported by in vitro experiments whereby stretching
of the kinase domain leads to activation of the kinase, thus
effectively linking mechanosensation to kinase activity
(“mechanozymatics”) [42]. Moreover, titin’s kinase domain
is linked via nbr1 and p62 to autophagy, a process of regulated
protein and organelle turnover [9].
However, the mechanism of tail release of the titin kinase
remains unclear [31], HMERF patients develop primarily a
skeletal muscle phenotype, and recently, mutations outside the
titin kinase domain have been found to cause HMERF, which
points to the presence of additional mechanisms [37, 41].
Clearly, inducible pluripotent stem cell-derived systems and
essential gain and loss of function models are needed to
understand the titin kinase-mediated pathways better.
Summary
where wall stresses are high, where sarcomeres are added in
parallel, and where cell survival pathways are activated to
avoid apoptosis. Other stresses such as shear stress and torque
may also be sensed by the Z-disc. The known macrostructural
changes of the sarcomeric Z-disc from the “basketweave”
formation in systole to the “small lattice” formation in diastole
may play a role here, but these conformational changes remain
poorly understood [40]. Aside from that, actomyosin interac-
tion may also link stretch to energy homeostasis (Fig. 1).
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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